CIK: 0001577524 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value ($000): $849,434 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BIIB | BIOGEN INC | 643,000 | $182,406 | 21.5% | $278.12 | +0.3% | COM | 09062X103 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 928,100 | $132,337 | 15.6% | $128.37 | -3.4% | SHS USD | G50871105 |
| ALKS | ALKERMES PLC | 7,825,000 | $129,660 | 15.3% | $18.71 | -2.9% | SHS | G01767105 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 14,040,000 | $126,289 | 14.9% | $11.68 | -14.9% | COM CL A | 46333X108 |
| — | ALEXION PHARMACEUTICALS INC | 797,740 | $91,285 | 10.7% | $108.59 | — | COM | 015351109 |
| INVA | INNOVIVA INC | 6,414,000 | $67,026 | 7.9% | $13.01 | -2.3% | COM | 45781M101 |
| — | MERSANA THERAPEUTICS INC | 2,837,000 | $52,824 | 6.2% | $6.52 | — | COM | 59045L106 |
| — | INTERCEPT PHARMACEUTICALS INC | 1,201,000 | $49,793 | 5.9% | $79.88 | — | COM | 45845P108 |
| BCRX | BioCryst Pharmaceuticals Inc | 4,861,000 | $16,697 | 2.0% | $4.22 | +1.5% | COM | 09058V103 |
| — | REGULUS THERAPEUTICS INC | 1,851,851 | $951 | 0.1% | $1.25 | — | COM NEW | 75915K200 |
| — | MIRATI THERAPEUTICS INC | 1,000 | $166 | 0.0% | $42.00 | — | COM | 60468T105 |